BNET -- AstraZeneca (AZN) may have discovered the future for pharmaceutical sales representatives: The company has axed virtually all its traditional reps — people who go door-to-door visiting doctors — on its Nexium heartburn franchise and replaced them with telemarketing call centers, where they only answer questions or visit doctors on request.
